MTOR and thyroid gland carcinoma: Further molecular mechanism studies revealed that SNHG3 knockdown upregulates key molecules in the AKT/mTOR and MAPK/ERK signaling pathways (p-AKT, p-mTOR, and p-ERK), thereby accelerating thyroid cancer progression (52).